Because perfusion status and degree of macular edema may differ in each patient of our study population, the inclusion of CRVO patients with lower VEGF levels may also have influenced in our findings regarding the non-significant differences in SFCT and PCT in CRVO-affected vs. contralateral eyes. This evidence concerns the gene VEGFA and macular retinal edema.